A detailed history of Engineers Gate Manager LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 38,592 shares of IONS stock, worth $1.74 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
38,592
Previous 28,877 33.64%
Holding current value
$1.74 Million
Previous $1.46 Million 14.52%
% of portfolio
0.05%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $408,321 - $520,238
9,715 Added 33.64%
38,592 $1.67 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $1.25 Million - $1.49 Million
28,877 New
28,877 $1.46 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $10,175 - $12,695
-293 Reduced 0.85%
34,047 $1.4 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $482,309 - $591,755
14,363 Added 71.9%
34,340 $1.23 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $500,526 - $627,275
13,484 Added 207.67%
19,977 $754,000
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $373,073 - $496,818
-10,210 Reduced 61.13%
6,493 $287,000
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $216,737 - $293,905
6,835 Added 69.26%
16,703 $618,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $732,418 - $907,924
-24,512 Reduced 71.3%
9,868 $366,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $453,501 - $621,550
17,708 Added 106.21%
34,380 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $559,178 - $676,049
16,672 New
16,672 $559,000
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $1.01 Million - $1.38 Million
-29,160 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $936,920 - $1.41 Million
22,040 Added 309.55%
29,160 $1.31 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $323,306 - $430,146
-7,137 Reduced 50.06%
7,120 $403,000
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $676,494 - $897,478
14,257 New
14,257 $676,000
Q2 2020

Aug 17, 2020

SELL
$46.85 - $61.05 $355,966 - $463,857
-7,598 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $255,964 - $390,100
-6,153 Reduced 44.75%
7,598 $359,000
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $740,491 - $897,527
13,751 New
13,751 $831,000
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $1.69 Million - $2.34 Million
-27,200 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $1.44 Million - $2.21 Million
27,200 New
27,200 $2.21 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.